COVID-19 XE Variant – An Emerging Threat
The emergence of a new COVID - 19 variant SARS Cov-2 Variant XE has raised concerns over its potential spread, triggering a pandemic if left unchecked.
Author:Suleman ShahReviewer:Han JuApr 26, 202218 Shares549 Views
The COVID - 19 XE variantis a mixture of the omicron subvariants BA.1 and BA.2. According to the World HealthOrganization, it was initially discovered in the United Kingdom on January 19, but it has since been reported in India. As of late March, around 600 cases had been found. The new variant has been found to cause more severe illnesses than the previous one. The emergence of this new variant has raised concerns over its potential spread, which could trigger a pandemic if left unchecked.
COVID-19 XE variant
How Is COVID - 19 XE Variant Different From Omicron?
Early estimates suggest that XE is 10% more transmissible than BA.2 – also known as "stealth omicron" – making it the most contagious variant yet. However, according to a recent WHO study, "this conclusion warrants additional validation." Its severity has not yet been determined. The development comes as BA.2 has established itself as the dominant variety globally and in the United States. While certain places in the United States have begun to notice a rise in new coronavirus infections, researchers do not anticipate BA.2 to cause another spike. WHO is tracking XE under the omicron umbrella, so it does not have its Greek letter name yet. According to the group, "XE is part of the omicron variety unless major differences in transmission and illness features, especially severity, are found."
What Are Recombinant Viruses?
Several viruses may exchange elements of their genetic make-up for becoming recombinant viruses. Characteristics from each strain merge into a hybrid virus. Recombination is to be predicted, although it is rare. This is a normal process that coronaviruses and other viruses go through. An undisclosed study found that 5% of COVID-19 cases in the United States and the United Kingdom were recombinant.
What Are The Symptoms Of COVID - 19 XE Variant Infection?
The intensity of COVID-19 symptoms varies from person to person, depending on vaccination status and immunity gained from previous infections. It is relatively common for some people's symptoms to alter, and for others, the changes may be pretty severe. The disease symptoms include fever, cough, shortness of breath, muscle pain, and weakness. Other symptoms may consist of a dry throat, headache, and loss of appetite. The disease spreads from human to human through direct contact and respiratory droplets. The virus is very hardy and can survive on various surfaces for long periods, including dust, fabric, food, and water. The easiest way to avoid the infection is not to get close enough that droplets will land on you.
According to WHO, the XE mutation is monitored as part of the Omicron variation. Fever, sore throat, scratchy throat, cough, cold, skin irritation and discoloration, and gastrointestinal trouble are all signs of Omicron.
Which Countries Are Most Affected By COVID - 19 XE Variant?
COVID-19 is quietly gaining a name for itself, with the potential to reshape the globe, even as many governments relax regulations and decrease testing and monitoring. Countries such as the United Kingdom (UK) have seen an increase in COVID-19 cases, with an average of 76,000 new infections per day, followed by Italy (around 70,000 per day), China (nearly 5,000 cases), Thailand (daily average of over 25,000), Israel (more than 14,000), Cyprus (daily average of around 4,908), France (more than 20,000 per day), Greece (over 20,000), and New Zealand (weekly average of 13,543). Many people are getting sick in many European countries, the EU Health Agency says. This includes France, Germany, Italy, the Netherlands, Poland, Belgium, and Austria.
The increase in new cases comes as the World Health Organization (WHO) issued a warning on Saturday about a new mutant 'XE' version of Omicron that may be more transmissible than any previous variation of COVID-19.
How Long Should A Patient With COVID - 19 XE Variant Be Treated?
The question of how long you should treat a patient with COVID - 19 remains unanswered as it is difficult to determine how long they will be contagious and whether they will show signs of improvement or worsen in their condition. ." I find it hard to believe there would be a case of someone getting sick in the next few days and that is why we are pulling back. Still, I don't know," said Dr. David Evans, director of infection prevention at Mount Sinai Hospital in Toronto.
The World Health Organization said that its expert committee decided that people who get the COVID vaccine might be much less likely to get sick or die from the spread of the omicron variant.
- It is also beneficial to keep the mask on and adhere to social distancing rules.
- Do not attend overcrowded events or venues.
- If you are at high risk of contracting a severe diseasesevereness, you may benefit from a booster dosage. As a consequence, a COVID booster dose is advised after immunization.
Conclusion
The World Health Organization has expressed alarm about the COVID - 19 XE Variant version of the infectious Omicron virus. The new sub-variant of said to be more transmissible than any other strain of COVID found.
Suleman Shah
Author
Suleman Shah is a researcher and freelance writer. As a researcher, he has worked with MNS University of Agriculture, Multan (Pakistan) and Texas A & M University (USA). He regularly writes science articles and blogs for science news website immersse.com and open access publishers OA Publishing London and Scientific Times. He loves to keep himself updated on scientific developments and convert these developments into everyday language to update the readers about the developments in the scientific era. His primary research focus is Plant sciences, and he contributed to this field by publishing his research in scientific journals and presenting his work at many Conferences.
Shah graduated from the University of Agriculture Faisalabad (Pakistan) and started his professional carrier with Jaffer Agro Services and later with the Agriculture Department of the Government of Pakistan. His research interest compelled and attracted him to proceed with his carrier in Plant sciences research. So, he started his Ph.D. in Soil Science at MNS University of Agriculture Multan (Pakistan). Later, he started working as a visiting scholar with Texas A&M University (USA).
Shah’s experience with big Open Excess publishers like Springers, Frontiers, MDPI, etc., testified to his belief in Open Access as a barrier-removing mechanism between researchers and the readers of their research. Shah believes that Open Access is revolutionizing the publication process and benefitting research in all fields.
Han Ju
Reviewer
Hello! I'm Han Ju, the heart behind World Wide Journals. My life is a unique tapestry woven from the threads of news, spirituality, and science, enriched by melodies from my guitar. Raised amidst tales of the ancient and the arcane, I developed a keen eye for the stories that truly matter. Through my work, I seek to bridge the seen with the unseen, marrying the rigor of science with the depth of spirituality.
Each article at World Wide Journals is a piece of this ongoing quest, blending analysis with personal reflection. Whether exploring quantum frontiers or strumming chords under the stars, my aim is to inspire and provoke thought, inviting you into a world where every discovery is a note in the grand symphony of existence.
Welcome aboard this journey of insight and exploration, where curiosity leads and music guides.
Latest Articles
Popular Articles